Zahnow, R and McVeigh, J and Bates, G and Hope, V and Kean, J and Campbell, J and Smith, J (2018)Identifying a typology of men who use An-

[1]  A. Christiansen,et al.  Outline of a typology of men’s use of anabolic androgenic steroids in fitness and strength training environments* , 2017 .

[2]  H. Pope,et al.  History and epidemiology of anabolic androgens in athletes and non-athletes , 2017, Molecular and Cellular Endocrinology.

[3]  R. Coomber,et al.  The risk environment of anabolic-androgenic steroid users in the UK: Examining motivations, practices and accounts of use. , 2017, The International journal on drug policy.

[4]  J. McVeigh,et al.  Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis , 2015, Substance Abuse Treatment, Prevention, and Policy.

[5]  R. Wood,et al.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. , 2014, Endocrine reviews.

[6]  D. Barceloux,et al.  Anabolic-androgenic steroids. , 2013, Disease-a-month : DM.

[7]  H. Pope,et al.  Illicit use of androgens and other hormones: recent advances , 2012, Current opinion in endocrinology, diabetes, and obesity.

[8]  M. Berglund,et al.  Anabolic Androgenic Steroids in the General Population: User Characteristics and Associations with Substance Use , 2012, European Addiction Research.

[9]  Andreas Kimergård,et al.  Elephant in the room? The methodological implications for public health research of performance-enhancing drugs derived from the illicit market. , 2009, Drug testing and analysis.

[10]  R. Dawson,et al.  Drugs in sport - the role of the physician. , 2001, The Journal of endocrinology.

[11]  Wadih Maalouf.  International Standards on Drug Use Prevention , 2015 .